• Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
  

PubMed=62724; DOI=10.1002/ijc.2910180513
George Klein, Jesper Zeuthen, Paul Ichiro Terasaki, Ronald James Billing, Ron Honig, Mikael Jondal, Anita Westman, Geoffrey Baverstock Clements;
Inducibility of the Epstein-Barr virus (EBV) cycle and surface marker properties of EBV-negative lymphoma lines and their in vitro EBV-converted sublines.
Int. J. Cancer 18:639-652(1976)

PubMed=175026; DOI=10.1002/ijc.2910170203
Karl-Otto Fresen, Harald zur Hausen;
Establishment of EBNA-expressing cell lines by infection of Epstein-Barr virus (EBV)-genome-negative human lymphoma cells with different EBV strains.
Int. J. Cancer 17:161-166(1976)

PubMed=191406; DOI=10.1002/ijc.2910190306
Karl-Otto Fresen, Barbara Merkt, Georg-Wilhelm Bornkamm, Harald zur Hausen;
Heterogeneity of Epstein-Barr virus originating from P3HR-1 cells. I Studies on EBNA induction.
Int. J. Cancer 19:317-323(1977)

PubMed=196397; DOI=10.1016/0042-6822(77)90065-4
Harald zur Hausen, Karl-Otto Fresen;
Heterogeneity of Epstein-Barr virus. II. Induction of early antigens (EA) by complementation.
Virology 81:138-143(1977)

PubMed=8449221; DOI=10.1002/eji.1830230325
Barbara Uchanska-Ziegler, Elfriede Noessner, Andrea Schenk, Andreas Ziegler, Dolores Jean Schendel;
Soluble T cell receptor-like properties of an HLA-B35-specific monoclonal antibody (TU165).
Eur. J. Immunol. 23:734-738(1993)